Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Clinical trial NCT03036930 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03036930
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Human Papillomavirus Infection Human Papillomavirus-Related Carcinoma

Start date: 2017-06-23
Primary completion: 2024-03-04
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.